131 related articles for article (PubMed ID: 22986081)
1. Psoriatic patients with diabetes are prone to develop digestive organ cancers: a population-based study in Taiwan.
Lan CC; Ko YC; Yu HS; Li WC; Wu CS; Lu YW; Yang YH; Chen GS
J Dermatol Sci; 2012 Nov; 68(2):82-8. PubMed ID: 22986081
[TBL] [Abstract][Full Text] [Related]
2. Arthritis as an important determinant for psoriatic patients to develop severe vascular events in Taiwan: a nation-wide study.
Chin YY; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1262-8. PubMed ID: 23004680
[TBL] [Abstract][Full Text] [Related]
3. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan.
Chen YJ; Wu CY; Chen TJ; Shen JL; Chu SY; Wang CB; Chang YT
J Am Acad Dermatol; 2011 Jul; 65(1):84-91. PubMed ID: 21458106
[TBL] [Abstract][Full Text] [Related]
4. The risk of developing non-melanoma skin cancer, lymphoma and melanoma in patients with psoriasis in Taiwan: a 10-year, population-based cohort study.
Lee MS; Lin RY; Chang YT; Lai MS
Int J Dermatol; 2012 Dec; 51(12):1454-60. PubMed ID: 23171012
[TBL] [Abstract][Full Text] [Related]
5. Association between antidiabetic drugs and psoriasis risk in diabetic patients: results from a nationwide nested case-control study in Taiwan.
Wu CY; Shieh JJ; Shen JL; Liu YY; Chang YT; Chen YJ
J Am Acad Dermatol; 2015 Jan; 72(1):123-30. PubMed ID: 25443628
[TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with having psoriatic arthritis in patients with cutaneous psoriasis.
Tey HL; Ee HL; Tan AS; Theng TS; Wong SN; Khoo SW
J Dermatol; 2010 May; 37(5):426-30. PubMed ID: 20536647
[TBL] [Abstract][Full Text] [Related]
7. Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study.
Chen YJ; Chang YT; Shen JL; Chen TT; Wang CB; Chen CM; Wu CY
Arthritis Rheum; 2012 Jun; 64(6):1879-87. PubMed ID: 22161801
[TBL] [Abstract][Full Text] [Related]
8. Co-morbidities in psoriasis: a hospital-based case-control study.
Tseng HW; Lin HS; Lam HC
J Eur Acad Dermatol Venereol; 2013 Nov; 27(11):1417-25. PubMed ID: 23134418
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for the development of psoriatic arthritis: a population based nested case control study.
Thumboo J; Uramoto K; Shbeeb MI; O'Fallon WM; Crowson CS; Gibson LE; Michet CJ; Gabriel SE
J Rheumatol; 2002 Apr; 29(4):757-62. PubMed ID: 11950018
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis and the metabolic syndrome.
Cohen AD; Gilutz H; Henkin Y; Zahger D; Shapiro J; Bonneh DY; Vardy DA
Acta Derm Venereol; 2007; 87(6):506-9. PubMed ID: 17989888
[TBL] [Abstract][Full Text] [Related]
11. Psoriasis and diabetes: a population-based cross-sectional study.
Cohen AD; Dreiher J; Shapiro Y; Vidavsky L; Vardy DA; Davidovici B; Meyerovitch J
J Eur Acad Dermatol Venereol; 2008 May; 22(5):585-9. PubMed ID: 18331320
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of metabolic syndrome in patients with psoriasis.
Nisa N; Qazi MA
Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
[TBL] [Abstract][Full Text] [Related]
13. The increased prevalence of non-alcoholic fatty liver disease in psoriatic patients: a study from South India.
Madanagobalane S; Anandan S
Australas J Dermatol; 2012 Aug; 53(3):190-7. PubMed ID: 22672067
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
[TBL] [Abstract][Full Text] [Related]
15. The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes M; Robinson D; Bala M; Kimball AB
J Am Acad Dermatol; 2009 Sep; 61(3):405-10. PubMed ID: 19700012
[TBL] [Abstract][Full Text] [Related]
16. Impact of obesity and smoking on psoriasis presentation and management.
Herron MD; Hinckley M; Hoffman MS; Papenfuss J; Hansen CB; Callis KP; Krueger GG
Arch Dermatol; 2005 Dec; 141(12):1527-34. PubMed ID: 16365253
[TBL] [Abstract][Full Text] [Related]
17. [Comorbidities in psoriatic patients of Iaşi Dermatological Clinic from 2004-2008].
Solovăstru GL; Vâţă D; Batog AH; Siriac O; Alupoaiei A; Diaconu D
Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):751-6. PubMed ID: 20191827
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy.
Su YS; Yu HS; Li WC; Ko YC; Chen GS; Wu CS; Lu YW; Yang YH; Lan CC
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):876-83. PubMed ID: 22702656
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome in untreated patients with psoriasis: case-control study.
Damevska K; Neloska L; Gocev G; Mihova M
J Dtsch Dermatol Ges; 2013 Dec; 11(12):1169-75. PubMed ID: 24267013
[TBL] [Abstract][Full Text] [Related]
20. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis.
Sommer DM; Jenisch S; Suchan M; Christophers E; Weichenthal M
Arch Dermatol Res; 2006 Dec; 298(7):321-8. PubMed ID: 17021763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
